People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Biotechnology, Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Edwards Lifesciences Corp | — | Biotechnology | Series D+ | $307.2M | $1.4B | 2017 |
| AcuFocus, Inc. | — | Biotechnology | Series C | $167.7M | $981.9M | 2016 |
| LENSAR, Inc. | — | Other Health Care | Series B | $119.0M | $185.0M | 2023 |
| Oyster Point Pharma, Inc. | — | Pharmaceuticals | Series C | $113.6M | $3.0B | 2017 |
| Cameron Health, Inc. | — | Other Health Care | Series C | $82.7M | $1.9B | 2011 |
| GLAUKOS Corp | — | Other Health Care | Series B | $76.0M | $664.6M | 2010 |
| Allegro Ophthalmics, LLC | — | Pharmaceuticals | Series B | $60.4M | $115.9M | 2017 |
| Prelude Corp | — | Biotechnology | Series A | $40.9M | $13.8M | 2017 |
| Orametrix Inc | — | Other Health Care | Series A | $26.5M | $41.7M | 2009 |
| Inogen Inc | — | Other Health Care | Series A | $14.2M | $194.6M | 2010 |
William J. Link at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside William J. Link on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.